Surveillance Strategies of Patients With Precancerous Conditions and Lesions in the Stomach

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

The project will aim to identify and determine subgroups of patients with different risks of progression to gastric cancer and to assess appropriate follow-up intervals. Implementing risk stratification only high risk individuals will be offered and performed endoscopic surveillance.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Patients undergoing upper endoscopy Motivation to participate in the study Signed consent

Locations
Other Locations
Latvia
University of Latvia
RECRUITING
Riga
Contact Information
Primary
Ilze Kikuste, PhD
ikikuste@gmail.com
28357349
Time Frame
Start Date: 2017-06-19
Estimated Completion Date: 2027-12
Participants
Target number of participants: 2000
Treatments
Gastric cancer
Gastric adenocarcinoma and other gastric malignancies
Gastric mucosal dysplasia
Includes: a. High-grade dysplasia; b. Low-grade dysplasia; c. Indefinite for dysplasia
High-risk IM gastritis stages
High-risk stages according to OLGIM classification: OLGIM Stage IV and OLGIM Stage III.
High-risk atrophic gastritis stages
High-risk stages according to OLGA classification: OLGA Stage IV and OLGA Stage III.
Extensive gastric intestinal metaplasia
Intestinal metaplasia of any grade both in gastric corpus and antrum/incisura (other than OLGIM III-IV).
Extensive atrophy
Moderate to severe (++ or +++) atrophy both in corpus and antrum/incisura, other than OLGA III-IV.
Isolated corpus atrophy
Isolated moderate-to-severe atrophy or IM in the corpus.
Related Therapeutic Areas
Sponsors
Collaborators: Riga East Clinical University Hospital, Academic Histology Laboratory (Latvia), Digestive Diseases Centre GASTRO
Leads: University of Latvia

This content was sourced from clinicaltrials.gov